sellWeak
David Patience sold $583 of AXDX
Chief Financial Officer at Accelerate Diagnostics, Inc. 535 shares at an average of $1.09, traded Feb 26, 2025, filed Feb 27, 2025.
Warning score
7Value
$583
535 shares
Holdings after
51,384
-1% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +22RoleCFO
- 0Trade size$583 at market
- 0Share of holdings soldSold 1.0% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001104659-25-018521, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 26, 2025 | MOption exercise Common Stock | +1,500 | $0.00 | $0 | 51,919 | Feb 27, 2025 |
| Feb 26, 2025 | SOpen-market sale Common Stock | -535 | $1.09 | $583 | 51,384 | Feb 27, 2025 |
| Feb 26, 2025 | MOption exercise Employee Restricted Stock Unitsderivative | -1,500 | $0.00 | $0 | 0 | Feb 27, 2025 |
Related signals
Other insiders at Accelerate Diagnostics, Inc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | Accelerate Diagnostics, Inc | Larry Michael Mertz Chief Technology Officer | $990 1,523 shares | -2% | |
| 30Weak | Accelerate Diagnostics, Inc | Jack Phillips Chief Executive Officer | $16k 25,343 shares | -12% | |
| 22Weak | Accelerate Diagnostics, Inc | David Patience Chief Financial Officer | $4,839 6,816 shares | -10% | |
| 10Weak | AXDXsell Accelerate Diagnostics, Inc | Jack Phillips Chief Executive Officer | $655 485 shares | -0% | |
| 29Weak | AXDXsell Accelerate Diagnostics, Inc | Jack W Schuler director, owner | $314k 200,000 shares | -2% | |
| 35Weak | AXDXbuy Accelerate Diagnostics, Inc | John Patience director | $314k 200,000 shares | +44% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.